Broteio Pharma

PIFA Therapeutics

Simibio

Simibio BV is an early stage company active in the development of therapeutic monoclonal antibodies. Antibodies are an important part of the body’s natural defense system and are normally produced by our immune system to help our bodies fight diseases such as cancer. Monoclonal antibodies are the dominant class of therapeutically important antibodies.